ICCAN Program for Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine how effectively the Integrated Cancer Care Access Network (ICCAN) program helps patients complete their cancer treatment and improves their quality of life. It compares the ICCAN program to regular hospital services, such as meetings with a Social Worker or Patient Navigator, in New York City hospitals. The trial targets cancer patients currently receiving or about to start chemotherapy or radiation therapy. Eligible participants should be fluent in English, Spanish, or Mandarin and plan to remain in the area for at least one year.
As an unphased trial, this study provides a unique opportunity to contribute to innovative cancer care solutions that could enhance treatment experiences for future patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the ICCAN program is safe?
Research has shown that the Integrated Cancer Care Access Network (ICCAN) positively impacts patients' treatment experiences. One study found that patients in the ICCAN program were more likely to complete their treatment and reported better outcomes than those receiving standard care. This suggests that patients generally respond well to the program.
Although specific safety data for ICCAN is limited, the absence of reported negative effects is reassuring. ICCAN provides guidance and resources, making it a low-risk option. This non-invasive support helps patients manage their treatment and access necessary resources.
Overall, evidence suggests that ICCAN is a safe and effective way to enhance cancer treatment experiences.12345Why are researchers excited about this trial?
Researchers are excited about the Integrated Cancer Care Access Network (ICCAN) trial because it aims to improve cancer treatment completion and quality of life, especially for underserved groups like Black, Hispanic, and low socioeconomic status patients with triple-negative breast cancer. Unlike standard treatments that primarily focus on medical care, ICCAN integrates social and economic support resources, potentially addressing key barriers to treatment adherence. By refining and testing this comprehensive support network, the trial hopes to reveal new ways to enhance the overall cancer care experience, potentially leading to better outcomes and improved quality of life for patients who might otherwise face significant challenges.
What evidence suggests that the ICCAN program is effective for cancer care?
Research has shown that the Integrated Cancer Care Access Network (ICCAN), which participants in this trial may receive, helps more patients complete their cancer treatments. Studies have found that patients in the ICCAN program experience better health and a higher quality of life compared to those receiving standard care. This program is particularly helpful for patients from low-income backgrounds, as it improves their access to necessary resources. The data indicates that ICCAN significantly aids patients in managing their cancer treatment effectively. Overall, evidence supports that ICCAN can improve treatment completion and enhance patient well-being.12467
Who Is on the Research Team?
Francesca Gany, MD, MS
Principal Investigator
Memorial Sloan Kettering Cancer Center
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the ICCAN program or standard hospital services for cancer treatment
Follow-up
Participants are monitored for treatment completion and quality of life outcomes
What Are the Treatments Tested in This Trial?
Interventions
- The Integrated Cancer Care Access Network (ICCAN)
- Usual and Customary Group (U&C)
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Arm 2 will consist of everything in Arm 1
Participants in this group will receive the same referrals on social and economic resources as ICCAN group.
10 Black, Hispanic, and/or low-SES patients with TNBC (5 Spanish-speaking), will be recruited from MSK
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor
Ralph Lauren Center for Cancer Care and Prevention
Collaborator
The City College of New York
Collaborator
Lincoln Medical and Mental Health Center
Collaborator
Lutheran Medical Center
Collaborator
National Cancer Institute (NCI)
Collaborator
Citations
Integrated Cancer Care Access Network
Data collected from ICCAN patients will help us to increase the number of patients who complete their cancer treatment, improve the quality of life for low- ...
Memorial Sloan Kettering
MSK is collecting data across four key levels to evaluate its access facilitators and the effectiveness of the ICCAN Network including metrics at the patient, ...
Impact of ICCAN on Cancer Treatment Completion and ...
The purpose of this 1 year study is to see if the ICCAN program is working, and to compare the ICCAN program to the standard hospital services provided in ...
Improving adherence to cancer care for socioeconomically ...
While ICCAN has been shown to increase treatment adherence and completion for patients with other cancers, it has not historically enrolled patients with CNS ...
A Randomized Controlled Trial of the Integrated Cancer ...
Conclusions: Patients in the ICCAN arm had significantly better treatment completion and patient-reported outcomes than those receiving U&C.
Study Details | NCT01742143 | Impact of ICCAN on Cancer ...
The purpose of this 1 year study is to see if the ICCAN program is working, and to compare the ICCAN program to the standard hospital services provided in ...
A Randomized Controlled Trial of the Integrated Cancer ...
Conclusions: Patients in the ICCAN arm had significantly better treatment completion and patient-reported outcomes than those receiving U&C.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.